Evaluation of the effects of glycated hemoglobin on cardiac function in patients with short-duration type 2 diabetes mellitus: a cardiovascular magnetic resonance study
Diabetic cardiomyopathy is a diabetes-related myopathy independent of recognized risk factors, such as hypertension or coronary artery disease [1], and characterized early by left ventricular (LV) diastolic dysfunction and later by heart failure. The risk of heart failure increases 2 –8 times in patients with type 2 diabetes mellitus (T2DM) [2]. However, there are no obvious clinical symptoms for diabetic cardiomyopathy, and LV ejection fraction (EF) was not a good marker of LV dysfunction at the early stage of diabetic cardiomyopathy [3].
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Fang-li Zhou, Ming-yan Deng, Li-Ling Deng, Yuan-mei Li, Dan Mo, Lin-jun Xie, Yue Gao, Hao-ming Tian, Ying-kun Guo, Yan Ren Source Type: research
More News: Cardiology | Cardiomyopathy | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Heart Failure | Hypertension | Study